Editorial

Editorial Editorial (2852) Total Article Views Authors: Glenn Lopate Published Date March 2011 Volume 2011:1 Pages 1 - 2 DOI: http://dx.doi.org/10.2147/DNND.S17825 Glenn Lopate Department of Neurology, Washington University of St. Louis, St. Louis, MO, USA The proposition to start a new journal is always a difficult one. However, the recent trend of open access journals has allowed publishers to expand the number of journals available to all scientists worldwide. The Directory of Open Access Journals1 lists 522 medical journals and 94 neurological journals, but only one with a focus on neurodegeneration. This new journal, Degenerative Neurological and Neuromuscular Disease, published by Dove Medical Press, will hopefully be able to fill that void. The idea for this journal was inspired by the aging population and the frequent occurrence of neurodegenerative diseases in this large group of patients. According to the United Nations Department of Economic and Social Affairs,2 in 1950 at the global level, 1 in 12 individuals was at least 60 years old and 1 in 20 was at least 65. By 2050 those numbers are projected to be 1 in 5 over 60 years old and 1 in 6 over 65. A recent PubMed search supports the idea that neurodegenerative diseases are quite common, with almost 600 articles published in 2010 under the search terms degenerative neurological disease or degenerative neuromuscular disease, a 25% increase from the number published 10 years earlier. Post to: Cannotea Citeulike Del.icio.us Facebook LinkedIn Twitter Readers of this article also read: Radiolucency below the crown of mandibular horizontal incompletely impacted third molars and acute inflammation in men with diabetes The cognitive impact of anticholinergics: A clinical review Alogliptin: a new addition to the class of DPP-4 inhibitors Lens-induced glaucoma in the elderly Lenalidomide in multiple myeloma: an evidence-based review of its role in therapy Tenofovir-associated bone density loss Morgellons disease: Analysis of a population with clinically confirmed microscopic subcutaneous fibers of unknown etiology Subset-directed antiviral treatment of 142 herpesvirus patients with chronic fatigue syndrome Pharmacogenetics in breast cancer: steps toward personalized medicine in breast cancer management Rituximab for refractory granulomatous eye disease